Tavapadon for Parkinson’s disease (Juvmo): FDA approval, how it works, and TEMPO results
Written and reviewed by Akbar Zaib, PhD in Neurosciences Tavapadon for Parkinson’s disease is a new treatment option approved by the U.S. FDA in September 2026. …